Yahoo Finance
Bloomberg Markets
On this episode of Stock Movers with Nathan Hager:
- Apogee (APGE) shares are soaring on news AbbVie is closing in on a nearly $11 billion deal to buy inflammatory disease drug developer Apogee Therapeutics. That's also according to a Financial Times report.
- Regenxbio (RGNX) shares are moving on news Regenxbio aligned with the FDA on next steps for a potential accelerated approval of Navsunli, a gene therapy for Mucopolysaccharidosis II, with the FDA confirming the company doesn’t need to co
Bloomberg Markets
Alamos Gold CEO John McCluskey joins Bloomberg Open Interest to explain the seismic disruption behind the company’s production cut, why he sees the setback as temporary, and why he rejects the idea that a weaker share price makes Alamos an M&A target. (Source: Bloomberg)
Bloomberg Markets
Falling Rhine water levels are choking fuel shipments to parts of western Europe as a heat wave grips the region, forcing barges to sail with less than half their normal loads.
NY Times Business
The daytime TV talk show is at the center of a dispute with the Federal Communications Commission over political speech.
Bloomberg Markets
This week, the Everybody's Business podcast hits the streets to ask New Yorkers how much they're paying for an ice cream cone.
Bloomberg's David Papadopoulos joins Stacey Vanek Smith and Max Chafkin to discuss how more and more things are out of reach for many Americans as inflation continues to outpace wages. (Source: Bloomberg)
Yahoo Finance